Capstone Investment Advisors’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
AIM
Capstone Investment Advisors's VCYT Position: Q2 2026 in Review
Capstone Investment Advisors sold out of Veracyte (VCYT) in Q2 2026, closing a stake of 12,708 shares — an estimated $409K sold.
Capstone Investment Advisors first reported a position in VCYT in Q1 2024 and held it in 5 quarters. The position peaked at $759K in Q1 2025. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.
- Capstone Investment Advisors reported no remaining Veracyte position as of Q2 2026 after selling out during the quarter.
- Capstone Investment Advisors sold 12,708 Veracyte shares in Q2 2026, an estimated $409K.
- Capstone Investment Advisors first reported a position in Veracyte in Q1 2024 and held it in 5 quarters.
- Capstone Investment Advisors's Veracyte position peaked at $759K in Q1 2025.
- 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.
Based on Capstone Investment Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.